Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1970 1
1971 2
1972 1
1974 2
1975 1
1983 1
1984 2
1986 3
1987 3
1988 1
1989 3
1990 1
1991 3
1992 1
1993 4
1994 1
1995 2
1996 1
1998 2
1999 1
2000 2
2001 3
2002 2
2003 3
2004 1
2006 2
2007 2
2008 3
2009 2
2010 4
2011 3
2012 6
2013 4
2014 11
2015 18
2016 21
2017 27
2018 21
2019 17
2020 16
2021 20
2022 15
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA, Ji L, Xu X, Devidas M, Hogan LE, Borowitz MJ, Raetz EA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Pulsipher MA, Hunger SP, Loh ML. Brown PA, et al. Among authors: bernhardt mb. JAMA. 2021 Mar 2;325(9):833-842. doi: 10.1001/jama.2021.0669. JAMA. 2021. PMID: 33651090 Free PMC article. Clinical Trial.
Organotherapy.
Bernhardt MS. Bernhardt MS. JAMA Dermatol. 2013 Dec;149(12):1366. doi: 10.1001/jamadermatol.2013.5877. JAMA Dermatol. 2013. PMID: 24352719 No abstract available.
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
Hogan LE, Brown PA, Ji L, Xu X, Devidas M, Bhatla T, Borowitz MJ, Raetz EA, Carroll A, Heerema NA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Hunger SP, Loh ML. Hogan LE, et al. Among authors: bernhardt mb. J Clin Oncol. 2023 Sep 1;41(25):4118-4129. doi: 10.1200/JCO.22.02200. Epub 2023 May 31. J Clin Oncol. 2023. PMID: 37257143 Clinical Trial.
Perleche.
Bernhardt M. Bernhardt M. Skinmed. 2022 Oct 31;20(5):362. eCollection 2022. Skinmed. 2022. PMID: 36314702 No abstract available.
ERASER.
Fiehler J, Thomalla G, Bernhardt M, Kniep H, Berlis A, Dorn F, Eckert B, Kemmling A, Langner S, Remonda L, Reith W, Rohde S, Möhlenbruch M, Bendszus M, Forkert ND, Gellissen S. Fiehler J, et al. Among authors: bernhardt m. Stroke. 2019 May;50(5):1275-1278. doi: 10.1161/STROKEAHA.119.024858. Stroke. 2019. PMID: 31009356 Clinical Trial.
Recent Advances in Melanoma Tumorigenesis.
Bernhardt M, Bernhardt A. Bernhardt M, et al. J Drugs Dermatol. 2022 Dec 1;21(12):1289-1293. doi: 10.36849/JDD.6814. J Drugs Dermatol. 2022. PMID: 36468958 Review.
Cervical spondylotic myelopathy.
Bernhardt M, Hynes RA, Blume HW, White AA 3rd. Bernhardt M, et al. J Bone Joint Surg Am. 1993 Jan;75(1):119-28. doi: 10.2106/00004623-199301000-00016. J Bone Joint Surg Am. 1993. PMID: 8419381 Review. No abstract available.
[Peripheral neuroblastic tumors in childhood].
Bernhardt M, Vokuhl C. Bernhardt M, et al. Pathologie (Heidelb). 2023 Nov;44(6):366-372. doi: 10.1007/s00292-023-01227-z. Epub 2023 Oct 11. Pathologie (Heidelb). 2023. PMID: 37819531 Review. German.
New Paradigms in Orthopedic Education.
Bogener JW, Bernhardt M, Cil A. Bogener JW, et al. Among authors: bernhardt m. Orthopedics. 2016 Sep 1;39(5):269-71. doi: 10.3928/01477447-20160823-02. Orthopedics. 2016. PMID: 27636682 No abstract available.
244 results